Finally, UBS Group dropped their price target on 10x Genomics from $20.00 to $14.00 and set a “neutral” rating for the company in a research report on Thursday, February 13th.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

FuriosaAI, a South Korean startup that makes chips for AI applications, has rejected an $800 million acquisition offer from Meta, opting instead to focus on developing and producing its AI chips ...

Performing cohesin HiChIP with an optimised fixation method results in a significantly better signal-to-noise ratio, higher ChIP efficiency and improved detection of chromatin loops and stripes.

Chip giant Taiwan Semiconductor Manufacturing Co. plans to invest a $100 billion in the United States, President Donald Trump announced Monday as he appeared with the company's head at the White ...

Blue chip stocks are from well-established companies with reliable profit records. They offer stable dividends and are favored for long-term investment security. Diversifying portfolios with blue ...

After hours: March 21 at 7:53:55 p.m. EDT Loading Chart for TXG ...

In reality, technology stocks aren't a homogenous entity – they're a collection of distinct groups and sub-sectors, each with their own growth profile and risk factors. The Global Industry ...

After hours: 21 March at 19:53:55 GMT-4 Loading Chart for TXG ...